Seegene, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2021
November 15, 2021 at 01:51 am EST
Share
Seegene, Inc. reported earnings results for the third quarter and nine months ended September 30, 2021. For the third quarter, the company reported sales was KRW 305,309.98 million compared to KRW 326,875.37 million a year ago. Net income was KRW 92,757.5 million compared to KRW 151,520.94 million a year ago. Basic earnings per share from continuing operations was KRW 1,793 compared to KRW 2,915 a year ago. Basic earnings per share was KRW 1,793 compared to KRW 2,915 a year ago.
For the nine months, sales was KRW 960,793.72 million compared to KRW 683,477.97 million a year ago. Net income was KRW 372,881.78 million compared to KRW 315,798.3 million a year ago. Basic earnings per share from continuing operations was KRW 7,188 compared to KRW 6,075 a year ago. Basic earnings per share was KRW 7,188 compared to KRW 6,075 a year ago.
Seegene Inc is a Korea-based company engaged in the development, manufacturing and distribution of molecular diagnostic reagents. The Company mainly provides infectious pathogens inspection products, including allergic respiratory pathogens, sexually transmitted diseases pathogens, human papilloma virus (HPV) and other inspection products, drug resistance inspection products, single nucleotide polymorphisms (SNP) inspection products, as well as somatic mutation cancer inspection products. In addition, it is involved in the provision of automatic real-time detection instruments. The Company provides its products under the brand names of Seeplex, Anyplex and Magicplex. The Company distributes its products within domestic market and to overseas markets.
SEEGENE, INC. 
